Immune Design Announces Advancement of First GLAAS™-based Allergy Program into Clinical Development
September 28, 2016 08:00 ET
|
Immune Design Corp
SEATTLE and SOUTH SAN FRANCISCO, Calif., Sept. 28, 2016 (GLOBE NEWSWIRE) -- Immune Design (Nasdaq:IMDZ), a clinical-stage immunotherapy company focused on cancer, today announced the application...
Immune Design Prices Public Offering of Common Stock
September 15, 2016 09:29 ET
|
Immune Design Corp
SEATTLE and SOUTH SAN FRANCISCO, Calif., Sept. 15, 2016 (GLOBE NEWSWIRE) -- Immune Design Corp. (Nasdaq:IMDZ) announced today the pricing of an underwritten public offering of 4,800,000...
Immune Design Announces Proposed Public Offering of Common Stock
September 14, 2016 16:05 ET
|
Immune Design Corp
SEATTLE and SOUTH SAN FRANCISCO, Calif., Sept. 14, 2016 (GLOBE NEWSWIRE) -- Immune Design Corp. (Nasdaq:IMDZ) announced today that it plans to offer and sell shares of its common stock in an...
Immune Design Reports Second Quarter 2016 Financial Results and Provides Corporate Update
August 09, 2016 16:02 ET
|
Immune Design Corp
SEATTLE and SOUTH SAN FRANCISCO, Aug. 09, 2016 (GLOBE NEWSWIRE) -- Immune Design (Nasdaq:IMDZ), a clinical-stage immunotherapy company focused on oncology, today reported financial results and a...
Immune Design to Report Second Quarter 2016 Financial Results
August 02, 2016 08:00 ET
|
Immune Design Corp
SEATTLE and SOUTH SAN FRANCISCO, Calif., Aug. 02, 2016 (GLOBE NEWSWIRE) -- Immune Design (Nasdaq:IMDZ), a clinical-stage immunotherapy company focused on cancer, today announced that it will report...
Immune Design Appoints Susan L. Kelley, M.D. to Board of Directors
June 16, 2016 08:00 ET
|
Immune Design Corp
SEATTLE and SOUTH SAN FRANCISCO, Calif., June 16, 2016 (GLOBE NEWSWIRE) -- Immune Design (Nasdaq:IMDZ), a clinical-stage immunotherapy company focused on cancer, today announced the appointment of...
Immune Design Releases New PFS, OS and TME Data from Trials of Three Immuno-Oncology Product Candidates
June 08, 2016 08:00 ET
|
Immune Design Corp
SEATTLE and SOUTH SAN FRANCISCO, Calif., June 08, 2016 (GLOBE NEWSWIRE) -- Immune Design (Nasdaq:IMDZ), a clinical-stage immunotherapy company focused on oncology, today announced updated results...
Immune Design Announces Upcoming Events
June 01, 2016 08:00 ET
|
Immune Design Corp.
- Jefferies 2016 Healthcare Conference Presentation -- Company Update Webcast June 8 in New York - SEATTLE and SOUTH SAN FRANCISCO, Calif., June 01, 2016 (GLOBE NEWSWIRE) -- Immune Design...
Immune Design to Present at UBS Global Healthcare Conference 2016
May 17, 2016 08:00 ET
|
Immune Design Corp.
SEATTLE and SOUTH SAN FRANCISCO, Calif., May 17, 2016 (GLOBE NEWSWIRE) -- Immune Design (Nasdaq:IMDZ), a clinical-stage immunotherapy company focused on oncology, today announced that Carlos Paya,...
Immune Design Reports First Quarter 2016 Financial Results and Provides Corporate Update
May 10, 2016 16:02 ET
|
Immune Design Corp.
SEATTLE and SOUTH SAN FRANCISCO, May 10, 2016 (GLOBE NEWSWIRE) -- Immune Design (Nasdaq:IMDZ), a clinical-stage immunotherapy company focused on oncology, today reported financial results and a...